Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Alpha Fusion and Curadh Enter into Partnership to Advance At-211 Radiopharmaceuticals
Details : The collaboration combines Alpha Fusion's leading role in At-211 drug discovery of af-001 and early clinical work in Japan, with Curadh's global expertise in radiopharmaceutical development.
Product Name : af-001
Product Type : Radiolabeled Compounds
Upfront Cash : Undisclosed
June 30, 2025
Details : The financing will be used for the development of Alpha Fusion's pipeline including Astatine-211, an element belonging to halogens and has the property of emitting alpha particle.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
July 03, 2023
Reset All
